USNA Earnings Date: Nov 3, 2026 (Estimated) — USANA Health Sciences, Inc.
NYSE · Consumer Staples · Packaged Foods
Updated
When is USNA's next earnings date?
USANA Health Sciences, Inc. (USNA) is expected to report Q3 2026 earnings on Tuesday, November 3, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.11 on revenue of $217.4M.
How did USNA do in its last earnings report?
In its most recent report on Aug 4, 2026 (Q2 2026), USANA Health Sciences, Inc. posted EPS of -$0.07 versus the $0.43 estimate, a miss of 116.3%. Revenue was $223.3M against a $235.0M estimate. The stock's 1-day post-earnings move was -34.2%.
How much does USNA stock move after earnings?
USNA beat EPS estimates in 5 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 8.2% (up or down) in the day after earnings.
About USANA Health Sciences, Inc.
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-04 | Q2 2026 | 0.43 | -0.07 | -116.28% | $223.3M | ❌ Miss | -34.20% | -39.60% | -36.08% |
| 2026-05-05 | Q1 2026 | 0.44 | 0.61 | +38.64% | $250.2M | ✅ Beat | +3.89% | -9.87% | -5.87% |
| 2026-02-17 | Q4 2025 | 0.41 | 0.60 | +46.34% | $226.2M | ✅ Beat | -8.03% | +4.84% | -17.28% |
| 2025-10-22 | Q3 2025 | -0.15 | -0.15 | +0.00% | $213.7M | ➖ Inline | -1.34% | -6.22% | -10.71% |
| 2025-04-22 | Q1 2025 | 0.70 | 0.73 | +4.29% | $249.5M | ✅ Beat | +4.91% | +15.06% | +22.77% |
| 2025-02-25 | Q4 2024 | 0.49 | 0.64 | +30.61% | $213.6M | ✅ Beat | +3.91% | -7.38% | -14.83% |
| 2024-10-22 | Q3 2024 | 0.48 | 0.56 | +16.67% | $200.2M | ✅ Beat | +6.09% | +8.18% | +14.62% |
| 2024-07-23 | Q2 2024 | 0.65 | 0.54 | -16.92% | $212.9M | ❌ Miss | -3.20% | -4.85% | -13.14% |
Showing last 8 quarters.
Revenue by segment & region
By region
Q2 FY26 · $380.4M total
| Segment | Share | Revenue | YoY | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|---|
| Asia Pacific | 41.3% | $157.1M | -3.7% | $337.8M | $173.4M | $163.2M | $139.4M |
| Greater China | 30.1% | $114.6M | +1.3% | $228.1M | $118.7M | $113.2M | $92.6M |
| Americas and Europe | 17.4% | $66.1M | -8.9% | — | $76.1M | $72.6M | $74.2M |
| Southeast Asia Pacific | 7.5% | $28.7M | -12.7% | $73.5M | $35.7M | $32.9M | $29.2M |
| North Asia | 3.6% | $13.8M | -19.5% | $36.3M | $18.9M | $17.2M | $17.7M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.